Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry
Advertisement

Related Content

Resisting Calls For More Freedom To Produce Generics For Export, Australia's IP Regime Is Safe For Now, But Generic Makers, Unions Ready For Battle
CSL CEO Brian McNamee On Being Australia's Only Homegrown MNC: An Interview With PharmAsia News (Part 2 of 2)
CSL CEO Brian McNamee On Being Australia’s Only Homegrown MNC: An Interview With PharmAsia News (Part 1 of 2)
Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotechs In 2009 Budget
Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget
Medicines Australia Says Pharmaceutical Benefits Scheme Spending Sustainable
Medicines Australia Makes $100,000 Donation To Bushfire Appeal Fund; Praises Govt Advisory Structure
Australia, New Zealand Consider Regulatory Reforms; PHARMAC To Add Sanofi Diabetes Agent Daonil: Australia, New Zealand Regulatory Roundup
AusBiotech Chief Executive Anna Lavelle On Biotech’s Role In Asia Pacific: An Interview with PharmAsia News (Part 1 of 2)
AusBiotech Chief Executive Anna Lavelle On Biotech’s Role In Asia Pacific: An Interview with PharmAsia News (Part 1 of 2)
Advertisement
UsernamePublicRestriction

Register

SC070838

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel